GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD4
|
ENSG00000141646.9 | SMAD family member 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD4 | hg19_v2_chr18_+_48494361_48494426 | 0.54 | 4.3e-18 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_117070037 | 34.46 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
chr22_+_23247030 | 33.92 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr11_-_111794446 | 27.73 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr14_-_106209368 | 22.50 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr6_-_33048483 | 21.03 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr2_+_113033164 | 19.41 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
chr11_-_5248294 | 18.98 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr7_+_94023873 | 18.83 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr22_-_27620603 | 18.76 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chr22_+_30752606 | 17.76 |
ENST00000399824.2
ENST00000405659.1 ENST00000338306.3 |
CCDC157
|
coiled-coil domain containing 157 |
chr5_-_42825983 | 17.65 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr5_+_150404904 | 17.23 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr1_-_31230650 | 17.06 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr3_-_112127981 | 15.97 |
ENST00000486726.2
|
RP11-231E6.1
|
RP11-231E6.1 |
chrX_+_38420783 | 15.77 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr22_+_22712087 | 15.67 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr9_+_124088860 | 15.32 |
ENST00000373806.1
|
GSN
|
gelsolin |
chr11_-_111781454 | 15.30 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr7_+_20686946 | 15.29 |
ENST00000443026.2
ENST00000406935.1 |
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
chr11_-_111781610 | 15.01 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr14_-_106237742 | 14.85 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr6_-_32908765 | 14.71 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chrX_+_38420623 | 14.47 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr8_-_90769422 | 14.04 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr19_-_36643329 | 13.87 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
chr2_+_89901292 | 13.78 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr9_+_139871948 | 13.60 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr15_-_45670924 | 13.44 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr22_+_22681656 | 13.33 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr6_+_32709119 | 13.26 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr12_-_91572278 | 13.24 |
ENST00000425043.1
ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN
|
decorin |
chr5_-_149792295 | 12.94 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr12_-_15104040 | 12.89 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr2_+_30454390 | 12.51 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr12_-_12491608 | 12.48 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
chr3_+_52529346 | 12.44 |
ENST00000321725.6
|
STAB1
|
stabilin 1 |
chr11_-_111781554 | 12.33 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr12_-_16758304 | 12.12 |
ENST00000320122.6
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr12_-_16758059 | 12.01 |
ENST00000261169.6
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr19_-_6720686 | 11.81 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr17_+_18128896 | 11.72 |
ENST00000316843.4
|
LLGL1
|
lethal giant larvae homolog 1 (Drosophila) |
chr12_-_15103621 | 11.58 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr7_+_23286182 | 11.45 |
ENST00000258733.4
ENST00000381990.2 ENST00000409458.3 ENST00000539136.1 ENST00000453162.2 |
GPNMB
|
glycoprotein (transmembrane) nmb |
chr10_-_105452917 | 11.40 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
chr17_+_77681075 | 11.35 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr9_-_34691201 | 11.27 |
ENST00000378800.3
ENST00000311925.2 |
CCL19
|
chemokine (C-C motif) ligand 19 |
chr16_-_30032610 | 11.23 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr22_+_22735135 | 11.16 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr3_+_183967409 | 10.93 |
ENST00000324557.4
ENST00000402825.3 |
ECE2
|
endothelin converting enzyme 2 |
chr14_-_106406090 | 10.80 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr10_-_90712520 | 10.56 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr19_+_56186606 | 10.52 |
ENST00000085079.7
|
EPN1
|
epsin 1 |
chr5_-_149535421 | 10.50 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr14_-_107131560 | 10.34 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr16_-_25122785 | 10.28 |
ENST00000563962.1
ENST00000569920.1 |
RP11-449H11.1
|
RP11-449H11.1 |
chr1_+_159175201 | 10.11 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chr17_+_41003166 | 9.96 |
ENST00000308423.2
|
AOC3
|
amine oxidase, copper containing 3 |
chr19_-_54784937 | 9.91 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr5_+_156696362 | 9.72 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr1_-_67142710 | 9.60 |
ENST00000502413.2
|
AL139147.1
|
Uncharacterized protein |
chr22_+_22930626 | 9.58 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr1_+_9005917 | 9.49 |
ENST00000549778.1
ENST00000480186.3 ENST00000377443.2 ENST00000377436.3 ENST00000377442.2 |
CA6
|
carbonic anhydrase VI |
chr9_+_124030338 | 9.48 |
ENST00000449773.1
ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN
|
gelsolin |
chr1_-_11865982 | 9.46 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr19_-_57183114 | 9.43 |
ENST00000537055.2
ENST00000601659.1 |
ZNF835
|
zinc finger protein 835 |
chr22_-_24641027 | 9.32 |
ENST00000398292.3
ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5
|
gamma-glutamyltransferase 5 |
chr22_+_22786288 | 9.28 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr2_-_89459813 | 9.28 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr16_+_1583567 | 9.23 |
ENST00000566264.1
|
TMEM204
|
transmembrane protein 204 |
chr22_+_23241661 | 9.22 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr19_-_11688447 | 9.10 |
ENST00000590420.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chr14_-_21491477 | 8.89 |
ENST00000298684.5
ENST00000557169.1 ENST00000553563.1 |
NDRG2
|
NDRG family member 2 |
chr10_+_26505594 | 8.83 |
ENST00000259271.3
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
chr2_-_89340242 | 8.80 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr13_-_27334879 | 8.68 |
ENST00000405846.3
|
GPR12
|
G protein-coupled receptor 12 |
chr12_-_49365501 | 8.64 |
ENST00000403957.1
ENST00000301061.4 |
WNT10B
|
wingless-type MMTV integration site family, member 10B |
chr7_+_99699280 | 8.54 |
ENST00000421755.1
|
AP4M1
|
adaptor-related protein complex 4, mu 1 subunit |
chr6_+_31582961 | 8.51 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr2_-_89513402 | 8.50 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr8_-_120605194 | 8.49 |
ENST00000522167.1
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr16_-_3306587 | 8.42 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
chr6_-_32908792 | 8.31 |
ENST00000418107.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chrX_-_139587225 | 8.28 |
ENST00000370536.2
|
SOX3
|
SRY (sex determining region Y)-box 3 |
chr19_-_36523709 | 8.23 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr22_+_23077065 | 8.22 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr14_-_106994333 | 8.22 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr19_-_11688500 | 8.20 |
ENST00000433365.2
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chr9_-_123476612 | 8.16 |
ENST00000426959.1
|
MEGF9
|
multiple EGF-like-domains 9 |
chr19_-_54784353 | 8.16 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr7_+_150130742 | 8.15 |
ENST00000477392.1
ENST00000486954.1 |
LINC00996
|
long intergenic non-protein coding RNA 996 |
chr12_+_124155652 | 8.05 |
ENST00000426174.2
ENST00000303372.5 |
TCTN2
|
tectonic family member 2 |
chr22_+_22707260 | 8.02 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr19_-_47164386 | 7.92 |
ENST00000391916.2
ENST00000410105.2 |
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr1_+_89829610 | 7.89 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
chr19_+_41768561 | 7.86 |
ENST00000599719.1
ENST00000601309.1 |
HNRNPUL1
|
heterogeneous nuclear ribonucleoprotein U-like 1 |
chr11_+_71927807 | 7.85 |
ENST00000298223.6
ENST00000454954.2 ENST00000541003.1 ENST00000539412.1 ENST00000536778.1 ENST00000535625.1 ENST00000321324.7 |
FOLR2
|
folate receptor 2 (fetal) |
chr17_-_18585541 | 7.81 |
ENST00000285274.5
ENST00000545289.1 ENST00000580145.1 |
ZNF286B
|
zinc finger protein 286B |
chr7_+_99699179 | 7.76 |
ENST00000438383.1
ENST00000429084.1 ENST00000359593.4 ENST00000439416.1 |
AP4M1
|
adaptor-related protein complex 4, mu 1 subunit |
chr7_-_129845313 | 7.69 |
ENST00000397622.2
|
TMEM209
|
transmembrane protein 209 |
chr1_-_113615699 | 7.67 |
ENST00000421157.1
|
RP11-31F15.2
|
RP11-31F15.2 |
chr22_-_50968419 | 7.65 |
ENST00000425169.1
ENST00000395680.1 ENST00000395681.1 ENST00000395678.3 ENST00000252029.3 |
TYMP
|
thymidine phosphorylase |
chr11_-_72385437 | 7.64 |
ENST00000418754.2
ENST00000542969.2 ENST00000334456.5 |
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr1_-_156390128 | 7.56 |
ENST00000368242.3
|
C1orf61
|
chromosome 1 open reading frame 61 |
chr2_+_89184868 | 7.56 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr1_-_11866034 | 7.51 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr8_-_48651648 | 7.49 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
chr16_+_33020496 | 7.43 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr17_+_47653178 | 7.37 |
ENST00000328741.5
|
NXPH3
|
neurexophilin 3 |
chr19_+_46171464 | 7.19 |
ENST00000590918.1
ENST00000263281.3 ENST00000304207.8 |
GIPR
|
gastric inhibitory polypeptide receptor |
chr8_+_28747884 | 7.19 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
chr6_-_11807277 | 7.19 |
ENST00000379415.2
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr12_-_99038732 | 7.18 |
ENST00000393042.3
ENST00000420861.1 ENST00000299157.4 ENST00000342502.2 |
IKBIP
|
IKBKB interacting protein |
chr20_-_524362 | 7.13 |
ENST00000460062.2
ENST00000608066.1 |
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide |
chr4_+_55524085 | 7.10 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr6_-_32095968 | 7.02 |
ENST00000375203.3
ENST00000375201.4 |
ATF6B
|
activating transcription factor 6 beta |
chr14_-_106878083 | 7.01 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr15_+_43803143 | 6.96 |
ENST00000382031.1
|
MAP1A
|
microtubule-associated protein 1A |
chr20_-_43883197 | 6.95 |
ENST00000338380.2
|
SLPI
|
secretory leukocyte peptidase inhibitor |
chr1_+_156123359 | 6.94 |
ENST00000368284.1
ENST00000368286.2 ENST00000438830.1 |
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr2_+_90153696 | 6.91 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr19_+_36359341 | 6.88 |
ENST00000221891.4
|
APLP1
|
amyloid beta (A4) precursor-like protein 1 |
chr2_+_89923550 | 6.87 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr10_-_81708854 | 6.86 |
ENST00000372292.3
|
SFTPD
|
surfactant protein D |
chr4_-_100242549 | 6.81 |
ENST00000305046.8
ENST00000394887.3 |
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide |
chr22_-_29711645 | 6.77 |
ENST00000401450.3
|
RASL10A
|
RAS-like, family 10, member A |
chr17_+_15602891 | 6.77 |
ENST00000421016.1
ENST00000593105.1 ENST00000580259.1 ENST00000583566.1 ENST00000472486.1 ENST00000395894.2 ENST00000581529.1 ENST00000579694.1 ENST00000580393.1 ENST00000585194.1 ENST00000583031.1 ENST00000464847.2 |
ZNF286A
|
Homo sapiens zinc finger protein 286A (ZNF286A), transcript variant 6, mRNA. |
chr2_+_220379052 | 6.75 |
ENST00000347842.3
ENST00000358078.4 |
ASIC4
|
acid-sensing (proton-gated) ion channel family member 4 |
chr19_-_51529849 | 6.75 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr22_-_38851205 | 6.74 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
chr3_+_133465228 | 6.71 |
ENST00000482271.1
ENST00000264998.3 |
TF
|
transferrin |
chr12_+_53443963 | 6.65 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr14_-_23834411 | 6.64 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr12_-_16759711 | 6.61 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr1_-_153321301 | 6.61 |
ENST00000368739.3
|
PGLYRP4
|
peptidoglycan recognition protein 4 |
chr12_-_11422739 | 6.61 |
ENST00000279573.7
|
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr17_+_30813576 | 6.54 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr1_-_160681593 | 6.51 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
chr17_+_61562178 | 6.51 |
ENST00000490216.2
|
ACE
|
angiotensin I converting enzyme |
chr4_+_74718906 | 6.49 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
chr2_+_127413481 | 6.47 |
ENST00000259254.4
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr17_-_61777459 | 6.47 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
chr14_-_106725723 | 6.46 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr16_-_28550348 | 6.42 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr19_+_51728316 | 6.37 |
ENST00000436584.2
ENST00000421133.2 ENST00000391796.3 ENST00000262262.4 |
CD33
|
CD33 molecule |
chr2_-_89417335 | 6.36 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr19_-_14952689 | 6.35 |
ENST00000248058.1
|
OR7A10
|
olfactory receptor, family 7, subfamily A, member 10 |
chr8_+_71383312 | 6.32 |
ENST00000520259.1
|
RP11-333A23.4
|
RP11-333A23.4 |
chr6_-_32731299 | 6.30 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr12_-_6798410 | 6.29 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
chr14_-_95942173 | 6.28 |
ENST00000334258.5
ENST00000557275.1 ENST00000553340.1 |
SYNE3
|
spectrin repeat containing, nuclear envelope family member 3 |
chr17_+_41006095 | 6.28 |
ENST00000591562.1
ENST00000588033.1 |
AOC3
|
amine oxidase, copper containing 3 |
chr2_+_16080659 | 6.27 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
chr5_-_35230434 | 6.26 |
ENST00000504500.1
|
PRLR
|
prolactin receptor |
chr1_-_28520447 | 6.22 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
chr17_-_19290117 | 6.21 |
ENST00000497081.2
|
MFAP4
|
microfibrillar-associated protein 4 |
chr17_+_61562201 | 6.20 |
ENST00000290863.6
ENST00000413513.3 ENST00000421982.2 |
ACE
|
angiotensin I converting enzyme |
chr10_-_73848531 | 6.19 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr3_+_111718036 | 6.17 |
ENST00000455401.2
|
TAGLN3
|
transgelin 3 |
chr15_-_60771128 | 6.16 |
ENST00000558512.1
ENST00000561114.1 |
NARG2
|
NMDA receptor regulated 2 |
chr20_-_56265680 | 6.10 |
ENST00000414037.1
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr1_-_151119087 | 6.07 |
ENST00000341697.3
ENST00000368914.3 |
SEMA6C
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
chr8_-_82359662 | 6.01 |
ENST00000519260.1
ENST00000256103.2 |
PMP2
|
peripheral myelin protein 2 |
chr11_+_124492749 | 6.01 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
chr14_+_61654271 | 5.97 |
ENST00000555185.1
ENST00000557294.1 ENST00000556778.1 |
PRKCH
|
protein kinase C, eta |
chr1_+_156123318 | 5.97 |
ENST00000368285.3
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr1_-_151345159 | 5.97 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr1_-_38157877 | 5.96 |
ENST00000477060.1
ENST00000491981.1 ENST00000488137.1 |
C1orf109
|
chromosome 1 open reading frame 109 |
chrX_+_128913906 | 5.95 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr7_+_150497491 | 5.95 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
chr5_-_149492904 | 5.94 |
ENST00000286301.3
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
chr1_-_111150048 | 5.92 |
ENST00000485317.1
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
chr19_-_17958832 | 5.84 |
ENST00000458235.1
|
JAK3
|
Janus kinase 3 |
chr3_-_16555150 | 5.80 |
ENST00000334133.4
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr4_-_186697044 | 5.80 |
ENST00000437304.2
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr6_+_31554962 | 5.80 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr12_-_42631529 | 5.77 |
ENST00000548917.1
|
YAF2
|
YY1 associated factor 2 |
chr5_-_168727786 | 5.77 |
ENST00000332966.8
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr16_-_30597000 | 5.75 |
ENST00000470110.1
ENST00000395216.2 |
ZNF785
|
zinc finger protein 785 |
chr12_+_121078355 | 5.74 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
chr4_-_926069 | 5.72 |
ENST00000314167.4
ENST00000502656.1 |
GAK
|
cyclin G associated kinase |
chr14_+_65007177 | 5.71 |
ENST00000247207.6
|
HSPA2
|
heat shock 70kDa protein 2 |
chr6_-_26189304 | 5.69 |
ENST00000340756.2
|
HIST1H4D
|
histone cluster 1, H4d |
chr8_-_125486755 | 5.69 |
ENST00000499418.2
ENST00000530778.1 |
RNF139-AS1
|
RNF139 antisense RNA 1 (head to head) |
chr9_-_123476719 | 5.57 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
chrX_-_153059958 | 5.57 |
ENST00000370092.3
ENST00000217901.5 |
IDH3G
|
isocitrate dehydrogenase 3 (NAD+) gamma |
chr14_-_106830057 | 5.56 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr6_-_169654139 | 5.55 |
ENST00000366787.3
|
THBS2
|
thrombospondin 2 |
chr7_-_135433460 | 5.55 |
ENST00000415751.1
|
FAM180A
|
family with sequence similarity 180, member A |
chr14_-_36989427 | 5.55 |
ENST00000354822.5
|
NKX2-1
|
NK2 homeobox 1 |
chr5_-_168728103 | 5.54 |
ENST00000519560.1
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr7_-_99573677 | 5.53 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chrX_+_18443703 | 5.51 |
ENST00000379996.3
|
CDKL5
|
cyclin-dependent kinase-like 5 |
chr1_+_44584522 | 5.51 |
ENST00000372299.3
|
KLF17
|
Kruppel-like factor 17 |
chr11_+_47270475 | 5.51 |
ENST00000481889.2
ENST00000436778.1 ENST00000531660.1 ENST00000407404.1 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
chrX_-_17879356 | 5.50 |
ENST00000331511.1
ENST00000415486.3 ENST00000545871.1 ENST00000451717.1 |
RAI2
|
retinoic acid induced 2 |
chr14_-_106552755 | 5.49 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr15_+_32933866 | 5.46 |
ENST00000300175.4
ENST00000413748.2 ENST00000494364.1 ENST00000497208.1 |
SCG5
|
secretogranin V (7B2 protein) |
chr1_-_158301312 | 5.45 |
ENST00000368168.3
|
CD1B
|
CD1b molecule |
chr22_+_22676808 | 5.44 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chrX_-_99987088 | 5.44 |
ENST00000372981.1
ENST00000263033.5 |
SYTL4
|
synaptotagmin-like 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 23.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
6.1 | 24.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.8 | 17.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
5.1 | 30.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
5.0 | 24.8 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
4.8 | 19.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
4.3 | 17.0 | GO:0071231 | cellular response to folic acid(GO:0071231) |
3.9 | 11.8 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
3.9 | 70.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
3.8 | 15.3 | GO:0048749 | compound eye development(GO:0048749) |
3.8 | 11.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
3.6 | 10.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
3.6 | 10.9 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
3.5 | 17.7 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
3.5 | 10.5 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
3.5 | 17.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.4 | 17.0 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
3.3 | 13.4 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
3.1 | 24.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
3.1 | 9.2 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
2.9 | 8.6 | GO:0051885 | positive regulation of anagen(GO:0051885) |
2.8 | 11.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
2.8 | 11.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.8 | 8.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
2.7 | 13.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.7 | 8.1 | GO:0001300 | chronological cell aging(GO:0001300) |
2.6 | 12.9 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.5 | 7.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
2.5 | 7.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
2.3 | 9.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.2 | 6.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.2 | 6.5 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
2.2 | 2.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.1 | 2.1 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
2.0 | 6.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.0 | 12.0 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
2.0 | 5.9 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.8 | 8.9 | GO:0006311 | meiotic gene conversion(GO:0006311) male meiosis chromosome segregation(GO:0007060) |
1.8 | 5.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.8 | 10.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
1.7 | 6.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.7 | 5.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
1.7 | 8.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
1.7 | 3.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.7 | 6.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.6 | 8.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.5 | 18.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.5 | 7.6 | GO:1904141 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
1.5 | 4.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.5 | 5.9 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.5 | 4.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.4 | 9.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.4 | 4.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
1.4 | 29.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.4 | 4.2 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
1.4 | 6.9 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
1.3 | 198.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.3 | 8.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.3 | 2.7 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
1.3 | 3.9 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.3 | 18.1 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
1.3 | 5.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.3 | 22.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 18.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.2 | 13.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.2 | 3.7 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
1.2 | 9.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.2 | 1.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) response to iron ion starvation(GO:1990641) |
1.2 | 10.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.2 | 6.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.2 | 4.8 | GO:0014028 | notochord formation(GO:0014028) |
1.2 | 5.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.2 | 3.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.2 | 8.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.2 | 7.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.2 | 3.5 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
1.2 | 9.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.2 | 1.2 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
1.2 | 5.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 3.3 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
1.1 | 10.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.0 | 4.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
1.0 | 3.1 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
1.0 | 3.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.0 | 7.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.0 | 9.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
1.0 | 3.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.0 | 4.9 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.0 | 3.9 | GO:0036343 | psychomotor behavior(GO:0036343) |
1.0 | 3.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
1.0 | 2.9 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
1.0 | 1.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.0 | 2.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.0 | 2.9 | GO:2000253 | regulation of skeletal muscle hypertrophy(GO:1904204) positive regulation of feeding behavior(GO:2000253) |
0.9 | 4.7 | GO:0021759 | globus pallidus development(GO:0021759) |
0.9 | 4.7 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.9 | 3.7 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.9 | 2.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.9 | 4.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.9 | 3.6 | GO:1990736 | positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.9 | 3.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.9 | 3.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.9 | 3.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 5.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.9 | 2.6 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.9 | 5.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.9 | 6.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.9 | 7.7 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.8 | 2.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 8.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 2.4 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.8 | 9.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.8 | 3.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 3.9 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.7 | 3.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.7 | 3.7 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.7 | 2.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.7 | 4.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 5.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 2.2 | GO:0032328 | alanine transport(GO:0032328) |
0.7 | 7.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 19.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.7 | 10.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.7 | 4.9 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.7 | 7.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 2.8 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.7 | 3.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.7 | 1.4 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.7 | 3.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 2.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.7 | 4.7 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.7 | 2.0 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.7 | 16.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 2.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.6 | 5.1 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 3.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 1.3 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.6 | 3.8 | GO:0061572 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.6 | 9.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 3.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.6 | 3.1 | GO:0072143 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.6 | 13.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.6 | 1.8 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.6 | 3.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 4.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.6 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.6 | 8.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 2.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.6 | 3.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.6 | 1.7 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.6 | 4.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.6 | 10.9 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.6 | 2.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.6 | 6.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.6 | 1.7 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.6 | 2.3 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.6 | 8.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 5.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.6 | 2.8 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.6 | 3.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.5 | 5.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 1.6 | GO:0060168 | regulation of axon diameter(GO:0031133) regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.5 | 5.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 2.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.5 | 2.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 21.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.5 | 2.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 2.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.5 | 11.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 2.5 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.5 | 6.9 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.5 | 7.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 2.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.5 | 8.8 | GO:0007530 | sex determination(GO:0007530) |
0.5 | 2.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 0.5 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.5 | 11.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.5 | 4.3 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
0.5 | 4.3 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.5 | 3.8 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.5 | 5.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 34.9 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.5 | 14.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.5 | 9.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.5 | 2.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.5 | 1.8 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.5 | 2.3 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.5 | 5.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 6.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 3.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 7.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.4 | 7.6 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.4 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 0.9 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.4 | 3.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.4 | 5.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 1.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 2.5 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.4 | 1.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 3.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.4 | 1.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 0.8 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.4 | 3.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.4 | 2.9 | GO:0046541 | saliva secretion(GO:0046541) |
0.4 | 3.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 7.4 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.4 | 4.0 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) |
0.4 | 12.9 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.4 | 2.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.4 | 3.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 5.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.4 | 3.1 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 3.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 1.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.4 | 55.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 2.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 5.8 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.4 | 2.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 3.6 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.4 | 3.9 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.3 | 0.7 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.3 | 3.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.3 | 4.1 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.3 | 6.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 3.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 3.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.3 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 1.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.3 | 4.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 1.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 7.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 1.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 3.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.3 | 1.2 | GO:0046668 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) regulation of retinal cell programmed cell death(GO:0046668) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.3 | 10.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 1.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.3 | 1.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 1.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.3 | 4.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.3 | 2.0 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.3 | 2.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 5.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.3 | 2.8 | GO:0042476 | odontogenesis(GO:0042476) |
0.3 | 1.7 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.3 | 0.8 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) sensory system development(GO:0048880) |
0.3 | 1.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 7.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 2.3 | GO:0048702 | protein sulfation(GO:0006477) embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 6.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 7.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.3 | 1.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 2.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 2.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 1.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 2.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 5.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 5.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 5.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 20.2 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 18.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.2 | 4.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 2.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.2 | 2.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 6.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 4.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 2.5 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.4 | GO:0032899 | neurotrophin production(GO:0032898) regulation of neurotrophin production(GO:0032899) negative regulation of neurotrophin production(GO:0032900) |
0.2 | 2.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 2.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.2 | 4.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 14.4 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.2 | 1.8 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 9.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 2.8 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 4.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.2 | 7.5 | GO:0050900 | leukocyte migration(GO:0050900) |
0.2 | 7.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 2.7 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.2 | 6.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 8.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 1.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.2 | 6.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 1.9 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 3.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 6.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 3.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 1.5 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 0.9 | GO:0007320 | insemination(GO:0007320) |
0.2 | 2.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 1.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 1.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.2 | 1.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 7.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 2.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 9.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 3.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.2 | 1.3 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 9.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 0.5 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 4.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.9 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 3.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 1.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 5.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 15.8 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 0.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 3.2 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 1.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 3.2 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 4.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 2.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 1.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 4.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 2.8 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 6.1 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.1 | 3.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 6.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 5.1 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 2.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.8 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.5 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 9.6 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 2.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 7.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 5.8 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.8 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 2.3 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 1.9 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 3.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 3.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 2.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 6.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 8.7 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 3.0 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.1 | 1.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 1.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 2.6 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 1.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 4.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 5.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 3.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 2.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.5 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 3.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 2.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 2.9 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 1.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 1.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.6 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
0.1 | 7.6 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 3.8 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
0.1 | 1.6 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 1.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 1.0 | GO:0030155 | regulation of cell adhesion(GO:0030155) |
0.1 | 7.0 | GO:0035821 | modification of morphology or physiology of other organism(GO:0035821) |
0.1 | 2.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.5 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.1 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0072538 | T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 1.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.5 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 1.0 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 3.5 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 3.2 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.9 | GO:0009790 | embryo development(GO:0009790) |
0.0 | 4.2 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 2.0 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 3.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 1.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 1.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 1.3 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 1.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.8 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 1.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 1.5 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 3.7 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
0.0 | 3.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 6.8 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 2.5 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 1.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 1.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 6.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 2.7 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 6.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
4.7 | 19.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.4 | 70.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.9 | 82.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.7 | 16.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.7 | 8.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
2.6 | 10.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.3 | 11.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
2.3 | 13.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
1.8 | 18.2 | GO:0071953 | elastic fiber(GO:0071953) |
1.8 | 8.9 | GO:0000801 | central element(GO:0000801) |
1.8 | 5.3 | GO:0097679 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
1.7 | 85.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.6 | 24.5 | GO:0030478 | actin cap(GO:0030478) |
1.6 | 9.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.6 | 18.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.4 | 4.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.2 | 6.1 | GO:0071546 | pi-body(GO:0071546) |
1.2 | 21.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.2 | 13.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.1 | 5.7 | GO:0036128 | CatSper complex(GO:0036128) |
1.1 | 3.3 | GO:0097440 | apical dendrite(GO:0097440) |
1.1 | 11.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 17.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.0 | 4.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 1.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.9 | 13.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.9 | 3.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 3.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.9 | 8.7 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.8 | 2.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.8 | 3.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.8 | 4.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.7 | 1.5 | GO:0031906 | late endosome lumen(GO:0031906) |
0.7 | 5.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 3.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 3.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 6.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.6 | 2.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.6 | 8.1 | GO:0036038 | MKS complex(GO:0036038) |
0.6 | 3.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 4.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.6 | 2.3 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 2.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.5 | 32.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 5.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 0.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.5 | 8.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 3.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 3.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 9.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 3.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 4.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 3.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 6.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 2.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 5.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 4.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 4.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 30.7 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 11.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.3 | 3.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 3.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 7.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 5.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 2.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.3 | 6.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 5.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 7.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 5.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 2.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 27.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.3 | 0.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 40.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 5.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 2.8 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 5.5 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.2 | 4.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 8.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 11.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 2.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 5.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 2.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 24.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 19.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 17.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 2.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 2.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 24.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 5.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.9 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.2 | 6.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 3.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 12.5 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 17.9 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.2 | 7.0 | GO:0009986 | cell surface(GO:0009986) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 12.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 5.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 3.0 | GO:0012506 | vesicle membrane(GO:0012506) |
0.2 | 3.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 14.0 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.2 | 2.3 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 7.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 3.0 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 189.9 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 5.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 10.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 3.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 7.6 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 2.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 8.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 2.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 4.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.8 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 1.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 7.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 6.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 9.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 8.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 5.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 2.8 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.9 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 1.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 4.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 9.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 108.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 1.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 3.1 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 1.6 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 2.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 6.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 4.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 3.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 2.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.9 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 2.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 3.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 1.7 | GO:0005925 | focal adhesion(GO:0005925) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
4.3 | 17.0 | GO:0061714 | folic acid receptor activity(GO:0061714) |
4.2 | 21.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
4.2 | 21.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
4.0 | 15.8 | GO:0097001 | ceramide binding(GO:0097001) |
3.6 | 14.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
3.5 | 46.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
3.4 | 17.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
3.2 | 19.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.1 | 24.5 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
2.8 | 11.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
2.8 | 8.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
2.7 | 10.9 | GO:0032810 | sterol response element binding(GO:0032810) |
2.5 | 27.0 | GO:0008430 | selenium binding(GO:0008430) |
2.3 | 23.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.3 | 11.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.3 | 70.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
2.2 | 6.7 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
2.2 | 13.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) peptidyl-dipeptidase activity(GO:0008241) |
2.2 | 6.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.2 | 15.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
2.2 | 6.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
2.1 | 8.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.1 | 24.8 | GO:0045159 | myosin II binding(GO:0045159) |
2.0 | 5.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.9 | 11.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.8 | 7.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.7 | 8.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.7 | 12.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.7 | 8.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.6 | 18.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.5 | 6.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.5 | 4.6 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.5 | 21.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.4 | 7.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.4 | 5.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.4 | 4.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.4 | 75.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.3 | 8.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.3 | 5.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.3 | 6.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.3 | 11.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.3 | 18.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.3 | 5.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.3 | 7.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.3 | 7.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.3 | 3.8 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
1.2 | 9.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.1 | 25.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.1 | 3.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.1 | 9.0 | GO:0005518 | collagen binding(GO:0005518) |
1.1 | 4.5 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.1 | 11.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.1 | 3.2 | GO:0034584 | piRNA binding(GO:0034584) |
1.1 | 3.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
1.1 | 182.3 | GO:0003823 | antigen binding(GO:0003823) |
1.0 | 3.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.0 | 13.4 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.0 | 3.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.0 | 5.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.0 | 6.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 5.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.0 | 8.1 | GO:0005534 | galactose binding(GO:0005534) |
1.0 | 4.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 4.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.0 | 3.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.0 | 2.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.0 | 5.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.9 | 5.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.9 | 2.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.9 | 2.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.8 | 14.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 3.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.8 | 20.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.8 | 2.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.8 | 4.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.8 | 3.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 3.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 2.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.7 | 8.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.7 | 3.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 10.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.7 | 3.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.7 | 7.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 4.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.7 | 3.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.6 | 1.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 3.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.6 | 16.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 10.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.6 | 2.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.6 | 2.4 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.6 | 1.8 | GO:0042806 | fucose binding(GO:0042806) |
0.6 | 6.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 2.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.6 | 1.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.6 | 2.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 9.0 | GO:0019864 | IgG binding(GO:0019864) |
0.6 | 2.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 2.8 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.6 | 3.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 3.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 12.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 3.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.5 | 13.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.5 | 9.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 2.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 15.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 3.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 11.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 2.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 7.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 8.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 2.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 3.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 5.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.5 | 5.1 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 1.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.5 | 4.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 9.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 2.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.4 | 6.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 7.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 6.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 3.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 1.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 3.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 0.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 4.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 4.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.4 | 8.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 5.3 | GO:0005030 | GPI-linked ephrin receptor activity(GO:0005004) neurotrophin receptor activity(GO:0005030) |
0.4 | 5.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 7.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 4.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 9.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.4 | 2.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 4.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.3 | 2.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.3 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 2.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 4.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.9 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.3 | 8.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 3.6 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.3 | 3.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 6.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 2.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 10.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.3 | 4.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.3 | 4.0 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.3 | 4.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 11.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 6.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.3 | 3.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 15.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 2.7 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 5.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 10.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 10.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 7.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.7 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.2 | 4.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 11.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 3.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 7.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 20.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 6.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 21.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 2.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 2.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 3.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 1.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 2.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 3.4 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) hormone receptor binding(GO:0051427) |
0.2 | 2.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 17.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 37.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 2.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 3.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 4.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 2.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 3.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.8 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.2 | 0.8 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 1.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 2.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 5.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 5.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 4.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 4.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 12.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 4.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 2.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 8.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 3.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 5.7 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) heterotrimeric G-protein binding(GO:0032795) |
0.1 | 3.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 2.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 1.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 5.1 | GO:0008289 | lipid binding(GO:0008289) |
0.1 | 1.1 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 5.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 3.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 10.7 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 1.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 6.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 4.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 2.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 2.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.7 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 4.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 1.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 2.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 3.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.5 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 1.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 19.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 2.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 23.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.6 | 64.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.6 | 31.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 33.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 12.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 4.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 79.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 4.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 15.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 20.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 4.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 2.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 48.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 11.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 3.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 10.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 10.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 11.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 11.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 2.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 10.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 6.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 5.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 4.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 12.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 5.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 3.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 42.9 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 11.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 7.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 2.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 5.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 5.9 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 6.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 6.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 6.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 3.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 14.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 50.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.5 | 25.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 11.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 22.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 14.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 15.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 21.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 48.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 11.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 9.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 7.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.5 | 19.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 0.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 10.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 14.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 7.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 4.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 13.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 7.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 8.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 12.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 8.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 4.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.4 | 27.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 12.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 34.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 8.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 10.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 6.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 4.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 7.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 5.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 16.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 5.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 9.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 3.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 8.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 1.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 3.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 6.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 4.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 5.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 8.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 3.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 12.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 4.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 5.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 4.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 18.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 14.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 7.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 26.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.2 | 4.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 2.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 11.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 9.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 1.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 8.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 5.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 12.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 4.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 3.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 24.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 6.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 3.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 7.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 3.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 3.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 9.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 3.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 5.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 8.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 3.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 3.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |